Nonalcoholic fatty liver disease (NAFLD) has emerged as the most frequent cause of liver
disease worldwide, comprising a plethora of conditions, ranging from steatosis to end‐stage …

Nonalcoholic fatty liver disease (NAFLD) is the hepatic component of the metabolic
syndrome. The aim of this review is to summarize the available data linking NAFLD with …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver
diseases in the Western society and its prevalence is likely to rise even further. An …

Nonalcoholic fatty liver disease (NAFLD), the most common of chronic liver disease in
Western Country, is closely related to insulin resistance and oxidative stress and includes a …

Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes and is present in up to one‐third of the general population. Evidence is …

As it affects almost every third individual in the general population in the Western world, non-
alcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide,
reflecting the current epidemics of obesity, insulin resistance and type 2 diabetes mellitus …

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are two
diseases that are common in the general population. To date, many studies have been …

Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population worldwide
and may confer increased cardiometabolic risk with consequent adverse cardiovascular …